Arcutis Biotherapeutics Stock Price on January 13, 2023

ARQT Stock  USD 14.62  0.06  0.41%   
If you're considering investing in Arcutis Stock, it is important to understand the factors that can impact its price. As of today, the current price of Arcutis Biotherapeutics stands at 14.62, as last reported on the 5th of January, with the highest price reaching 14.98 and the lowest price hitting 14.36 during the day. Arcutis Biotherapeutics appears to be somewhat reliable, given 3 months investment horizon. Arcutis Biotherapeutics secures Sharpe Ratio (or Efficiency) of 0.17, which signifies that the company had a 0.17% return per unit of standard deviation over the last 3 months. By analyzing Arcutis Biotherapeutics' technical indicators, you can evaluate if the expected return of 0.73% is justified by implied risk. Please makes use of Arcutis Biotherapeutics' mean deviation of 3.19, and Risk Adjusted Performance of 0.1479 to double-check if our risk estimates are consistent with your expectations.
  
Arcutis Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1724

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsARQT
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 4.21
  actual daily
37
63% of assets are more volatile

Expected Return

 0.73
  actual daily
14
86% of assets have higher returns

Risk-Adjusted Return

 0.17
  actual daily
13
87% of assets perform better
Based on monthly moving average Arcutis Biotherapeutics is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Arcutis Biotherapeutics by adding it to a well-diversified portfolio.

Arcutis Biotherapeutics Valuation on January 13, 2023

It is possible to determine the worth of Arcutis Biotherapeutics on a given historical date. On January 13, 2023 Arcutis was worth 13.63 at the beginning of the trading date compared to the closed value of 14.12. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Arcutis Biotherapeutics stock. Still, in general, we apply an absolute valuation method to find Arcutis Biotherapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Arcutis Biotherapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Arcutis Biotherapeutics' related companies.
 Open High Low Close Volume
  13.59    13.84    12.83    13.81    1,469,365  
01/13/2023
  13.63    14.14    13.63    14.12    812,130  
  14.20    14.73    13.57    14.67    1,262,800  
Backtest Arcutis Biotherapeutics  |  Arcutis Biotherapeutics History  |  Arcutis Biotherapeutics Valuation   PreviousNext  
Open Value
13.63
14.12
Closing Value
26.25
Upside

Arcutis Biotherapeutics Trading Date Momentum on January 13, 2023

On January 17 2023 Arcutis Biotherapeutics was traded for  14.67  at the closing time. The top price for the day was 14.73  and the lowest listed price was  13.57 . The trading volume for the day was 1.3 M. The trading history from January 17, 2023 was a factor to the next trading day price appreciation. The overall trading delta against the next closing price was 3.90% . The overall trading delta against the current closing price is 15.37% .

Arcutis Biotherapeutics Fundamentals Correlations and Trends

By evaluating Arcutis Biotherapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Arcutis Biotherapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Arcutis financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Arcutis Biotherapeutics Stock history

Arcutis Biotherapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Arcutis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Arcutis Biotherapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Arcutis Biotherapeutics stock prices may prove useful in developing a viable investing in Arcutis Biotherapeutics
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California. Arcutis Biotherapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 147 people.

Arcutis Biotherapeutics Stock Technical Analysis

Arcutis Biotherapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Arcutis Biotherapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Arcutis Biotherapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Arcutis Biotherapeutics Period Price Range

Low
January 5, 2025
0.00  NaN%
High

 0.00 

     

 0.00 

Arcutis Biotherapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Arcutis Biotherapeutics January 5, 2025 Market Strength

Market strength indicators help investors to evaluate how Arcutis Biotherapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Arcutis Biotherapeutics shares will generate the highest return on investment. By undertsting and applying Arcutis Biotherapeutics stock market strength indicators, traders can identify Arcutis Biotherapeutics entry and exit signals to maximize returns

Arcutis Biotherapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Arcutis Biotherapeutics' price direction in advance. Along with the technical and fundamental analysis of Arcutis Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Arcutis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Arcutis Stock Analysis

When running Arcutis Biotherapeutics' price analysis, check to measure Arcutis Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcutis Biotherapeutics is operating at the current time. Most of Arcutis Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Arcutis Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcutis Biotherapeutics' price. Additionally, you may evaluate how the addition of Arcutis Biotherapeutics to your portfolios can decrease your overall portfolio volatility.